Arigoni C, Rusca A, Pusterla C E, Beretta-Piccoli C
Ospedale Italiano, Viganello.
Schweiz Med Wochenschr. 1987 Jul 25;117(30):1152-7.
Calcium antagonists have been used for the acute treatment of hypertension. Among these compounds, diltiazem induces the least tachycardia in response to acute administration. The effects of this agent, in a dose of 0.3 mg/kg given intravenously, on arterial pressure, heart rate and plasma renin activity were assessed in 10 patients with benign moderate to severe essential hypertension; nifedipine (10 mg sublingually) in 10 patients or 5% glucose (placebo) in 4 patients was used as a control. As compared with the 5% glucose group, diltiazem caused a persistent fall in diastolic pressure during 60 minutes, but only a transient decrease in systolic arterial pressure and heart rate; plasma renin activity was unchanged. Nifedipine caused a persistent fall in both systolic and diastolic pressure and a slight but significant increase in plasma renin activity, but did not modify heart rate. The diltiazem-induced decrease in systolic pressure was significantly smaller than the pressure changes caused by nifedipine. Variations in plasma renin activity between the two calcium antagonists were not significant. These findings suggest that in patients with hypertension diltiazem exerts a less marked acute antihypertensive effect than nifedipine.
钙拮抗剂已用于高血压的急性治疗。在这些化合物中,地尔硫䓬静脉急性给药时引起的心动过速最少。对10例良性中度至重度原发性高血压患者评估了静脉注射剂量为0.3mg/kg的该药物对动脉压、心率和血浆肾素活性的影响;以10例患者舌下含服硝苯地平(10mg)或4例患者静脉输注5%葡萄糖(安慰剂)作为对照。与5%葡萄糖组相比,地尔硫䓬在60分钟内使舒张压持续下降,但仅使收缩压和心率短暂降低;血浆肾素活性未改变。硝苯地平使收缩压和舒张压持续下降,血浆肾素活性轻微但显著升高,但未改变心率。地尔硫䓬引起的收缩压下降明显小于硝苯地平引起的血压变化。两种钙拮抗剂之间血浆肾素活性的变化不显著。这些发现表明,在高血压患者中,地尔硫䓬的急性降压作用不如硝苯地平显著。